The T-Cell Response to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease is Augmented with Anti-TNF Therapy

Dalin Li, Alexander M. Xu, Emebet Mengesha, Rebecca Elyanow, Rachel Gittelman, Heidi Chapman, John C. Prostko, Edwin C. Frias, James L. Stewart, Valeriya Pozdnyakova,

Inflammatory Bowel Diseases · 2022 · 33 citations · 13 references

DOIFull text

Open access

Concepts

Abstract

Lay Summary T-cell and antibody responses to severe acute respiratory syndrome coronavirus 2 vaccination in inflammatory bowel disease patients are poorly correlated. T-cell responses are preserved by most biologic therapies, but augmented by anti-tumor necrosis factor (anti-TNF) treatment. While anti-TNF therapy blunts the antibody response, cellular immunity after vaccination is robust.

References

13